National class action law firm offers free, confidential case evaluations to AECOM employees, clients, and others whose personal information may have been exposed in the reported AECOM data breach.

DALLAS, Sept. 20, 2026 /PRNewswire/ — Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from a reported data breach at AECOM, the U.S.-based multinational infrastructure and engineering firm. Anyone who has received a data breach notice from AECOM, or who believes their personal information may have been exposed, can request a free case evaluation.

AECOM data breach — at a glance:

Company: AECOM, a Texas-based, multibillion-dollar multinational infrastructure consulting, engineering, design, and construction management firm.Reported: A cyberattack said to have occurred on or about September 17, 2026, first surfaced on dark web monitoring sites.Hackers’ claims: The group Metaencryptor claimed responsibility for an attack said to involve approximately 1.22 terabytes (TB) of data. Separately, dark web monitoring service Breachsense listed a related AECOM leak of roughly 670GB attributed to a group identified as BrainCipher.Status: The breach and the hackers’ claims remain unconfirmed. AECOM has not publicly detailed the scope or impact.Who may be affected: Current and former AECOM employees, clients, and others whose data AECOM held.Cost to you: Nothing. Case evaluations are free and confidential.

What Happened

According to a September 17, 2026 post on the dark web monitoring site Ransomware.live, the hacker group Metaencryptor claimed responsibility for a cyberattack on AECOM that allegedly affected about 1.22 TB of data. The cybersecurity blog HookPhish similarly reported that Metaencryptor was behind a suspected attack on the engineering firm.

Separately, the dark web monitoring service Breachsense reported an AECOM data leak listed at approximately 670GB, attributed to a group it identified as BrainCipher. Breachsense also indexed thousands of AECOM-linked credentials circulating online, including 27,434 @aecom.com accounts drawn from external breaches and 6,077 credentials tied to aecom.com itself — among them thousands of logins found in “combo lists” and in infostealer malware logs, many with plaintext passwords. Breachsense cautioned that those credentials may belong to either customers or staff and are not necessarily connected to the claimed attack.

The breach has not been confirmed, and important details (including its true scope, the specific data involved, and the number of people affected) are not yet publicly available.

What Personal Information May Be at Risk

The specific data involved in the reported AECOM data breach has not been confirmed. Data breaches like this can expose personal information, increasing the risk of identity theft and fraud. Affected individuals should treat any AECOM breach notification seriously.

Who May Be Affected by the AECOM Data Breach

The investigation focuses on current and former AECOM employees, clients, and anyone else whose personal information AECOM maintained. Anyone who has received a data breach notification from AECOM may face an increased risk of identity theft and fraud and is encouraged to come forward.

Your Legal Options

Edelson Lechtzin LLP is investigating a potential class action to pursue legal remedies on behalf of individuals whose sensitive personal data may have been compromised in the reported AECOM breach. A successful case could recover compensation for losses such as lost time, out-of-pocket costs, and loss of privacy, and could push AECOM to strengthen how it protects personal information. The firm will evaluate your rights and potential claims at no cost.

Recommended Steps to Protect Yourself

Review your account statements and credit reports regularly and stay alert for suspicious activity.Confirm whether your information was involved in the AECOM incident.Preserve any letters or emails you received about the breach.Consider placing fraud alerts and enrolling in credit monitoring.

Contact Us for a Free Case Evaluation

Speak confidentially with a data privacy attorney today: Marc Edelson, Esq., Edelson Lechtzin LLP, 411 S. State Street, Suite N-300, Newtown, PA 18940; Phone: 844-696-7492; Email: medelson@edelson-law.com; Web: www.edelson-law.com. Or click HERE to request a free consultation.

About Edelson Lechtzin LLP

Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to data breach litigation, the firm handles class and collective actions involving securities and investment fraud, federal antitrust violations, ERISA employee benefit plans, wage theft, and consumer fraud.

Media and Partnership Inquiries: Use the contact information above to connect with our team regarding interviews, co-counsel opportunities, and referral partnerships.

Legal Notice: This press release may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee a similar outcome. The reported data breach and the hackers’ claims described above are unconfirmed.

View original content to download multimedia:https://www.prnewswire.com/news-releases/aecom-data-breach-investigation-edelson-lechtzin-llp-probes-class-action-claims-after-hackers-allege-theft-of-more-than-1-tb-of-data-302884076.html

SOURCE Edelson Lechtzin LLP

Extra-large widget experiences, iOS 27-inspired themes and new customization tools drive iScreen’s latest global growth

LOS ANGELES, Sept. 20, 2026 /PRNewswire/ — iScreen, a mobile customization app for iOS and Android, announced that it has reached No. 1 in the Graphics & Design category across 94 countries and regions following its latest iOS 27-focused update.

The update expands iScreen’s Home Screen customization experience with new extra-large widgets, iOS 27-inspired themes, layouts optimized for new screen proportions, and AI-assisted design tools.

Extra-Large Widgets

Built for the larger widget canvas available in iOS 27, iScreen’s new extra-large widgets go beyond simply scaling up existing formats. The collection includes Photo, Album, Music, Calendar, Interactive Refrigerator and Quick Launch widgets, among others. Users can also customize content, layouts and visual styles to create more functional and expressive Home Screen experiences.

iOS 27-Inspired Themes and iPhone Duo Theme Support

iScreen has introduced new iOS 27-inspired themes that combine coordinated wallpapers, transparent-style widgets, icons and other visual elements into complete Home Screen setups.

Selected themes have also been optimized for iPhone Duo’s screen proportions and display dimensions, with wallpapers, widgets and icons adjusted to better fit the new format while maintaining a cohesive visual experience.

AI-Assisted Home Screen Design

iScreen is also testing AI Home Screen Designer with a limited group of users. The feature generates coordinated design suggestions based on users’ preferences for style, color and visual elements, combining wallpapers, widgets and icons into a unified setup.

“The latest iOS update has opened up new possibilities for mobile personalization,” said the iScreen team. “We want to turn those capabilities into practical and creative experiences that make Home Screen design easier and more expressive.”

About iScreen

iScreen is a mobile customization app offering widgets, wallpapers, themes and Home Screen customization tools for iOS and Android devices. With more than 100 million users worldwide, iScreen has ranked No. 1 in Graphics & Design across 94 countries and regions and has been featured by Apple Editorial in 128 countries for five consecutive days.

Official Website: iScreen – Phone Style, iScreen it!
iOS Download: ‎‎iScreen – Widgets & Wallpaper App – App Store
Android Download: iScreen Google Play

View original content:https://www.prnewswire.co.uk/news-releases/iscreen-reaches-no-1-in-graphics–design-across-94-markets-following-ios-27-update-302883972.html

Late-breaking HRX data advance Field Medical’s “instantaneous ablation” workflow and expand the clinical evidence for high-voltage focal PFA with the FieldForce™ PFA System

ATLANTA and CARLSBAD, Calif., Sept. 20, 2026 /PRNewswire/ — Field Medical, Inc., advancing high-voltage focal pulsed field ablation (PFA) for complex arrhythmias, today announced publication of 12-month results from the first-in-human Field PULSE trial in JACC: Clinical Electrophysiology. The findings were presented simultaneously as a Late-Breaking Clinical Trial at HRX Live 2026.

Field Medical developed the FieldForce™ PFA System around a high-voltage focal PFA architecture designed first for the ventricle, where depth, stability and control are among the most difficult challenges in ablation. Field PULSE extends that work into the atrium and evaluates a subsecond point-by-point workflow Field Medical terms “instantaneous ablation.” In this study, the approach was associated with procedural efficiency, durable pulmonary vein isolation (PVI) and flexibility beyond the pulmonary veins, without the need for prolonged catheter stability.

Key Findings:

Procedural efficiency with subsecond focal PFA: 13-minute median elapsed PVI ablation time, with a fastest time of 7.7 minutesDurable PVI with the optimized waveform: 94.2% per-vein durability reflecting progressive improvement with waveform evolutionFlexible focal ablation: 49% of patients received non-PV ablation for additional atrial targetsNo primary safety events were observed80% freedom from atrial arrhythmias at 12 months with the optimized waveform

“Field PULSE demonstrates the feasibility of truly instantaneous focal PFA,” said Vivek Reddy, M.D., co-principal investigator, lead author and electrophysiologist at Mount Sinai Health System. “Delivering the full application in less than 200 milliseconds reduces the need for prolonged catheter stability while preserving the flexibility of point-by-point ablation. The procedural efficiency, safety and pulmonary vein durability observed with the optimized waveform support continued clinical development of this approach.”

The publication builds on Field Medical’s peer-reviewed clinical work in ventricular tachycardia. Six-month outcomes from the company’s first-in-human VCAS trial were published in Circulation in 2025. Field PULSE now adds first-in-human, peer-reviewed atrial data evaluating the same high-voltage focal PFA architecture through a distinct focal workflow in a different cardiac substrate.

“We designed FieldForce to solve some of the hardest problems in focal cardiac ablation, beginning in the ventricle,” said Mark A. Turco, M.D., president and chief executive officer of Field Medical. “Field PULSE demonstrates that the same high-voltage focal PFA architecture can support an ‘instantaneous ablation’ workflow in the atrium. This growing body of evidence reinforces the range of the platform: depth and focal control in the ventricle, speed and precision in the atrium, and the versatility to address very different cardiac substrates through a familiar point-by-point approach. These results add important clinical evidence as we continue to advance our differentiated PFA platform.”

The study, “High-Voltage Focal PFA Catheter for ‘Instant’ Point-By-Point Ablation: The First-In-Human FIELD-PULSE Trial to Treat AF,” was published online in JACC: Clinical Electrophysiology concurrent with the HRX presentation. DOI: 10.1016/j.jacep.2026.09.001.

About Field Medical®, Inc.
Field Medical is a clinical-stage medical technology company committed to advancing pulsed field ablation (PFA) solutions for complex cardiac arrhythmias. The company was founded by Steven Mickelsen, M.D., CTO, a pioneer and global thought leader in PFA whose work has helped shape the evolution of the field. The FieldForce PFA System integrates a focal catheter design with proprietary FieldBending™ energy designed to safely deliver efficient, precise ablation with the goal of improving outcomes in ventricular and atrial arrhythmia treatment. In 2024, Field Medical earned Breakthrough Device Designation and gained entry into the FDA TAP Pilot Program for its ventricular tachycardia indication. In October 2025, the VCAS trial was published in Circulation.

For more information, visit fieldmedicalinc.com and follow us on LinkedIn and YouTube.

The FieldForce™ PFA System is an investigational device and is limited by federal (or United States) law to investigational use.

Media Contact
Holly Windler
619.929.1275
media@fieldmedicalinc.com

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/jacc-clinical-electrophysiology-publishes-12-month-outcomes-from-field-medicals-first-in-human-field-pulse-trial-94-2-per-vein-pvi-durability-with-optimized-waveform-302883888.html